Getting to the Surface: A Link Between Tumor Antigen Discovery and Natural Presentation of Peptide-MHC Complexes
- 1 August 2005
- journal article
- editorial
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (15) , 5333-5336
- https://doi.org/10.1158/1078-0432.ccr-05-1057
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Determination of Cellularly Processed HLA-A2402-Restricted Novel CTL Epitopes Derived from Two Cancer Germ Line Genes, MAGE-A4 and SAGEClinical Cancer Research, 2005
- Phase I Study of Sequential Vaccinations With Fowlpox-CEA(6D)-TRICOM Alone and Sequentially With Vaccinia-CEA(6D)-TRICOM, With and Without Granulocyte-Macrophage Colony-Stimulating Factor, in Patients With Carcinoembryonic Antigen–Expressing CarcinomasJournal of Clinical Oncology, 2005
- A listing of human tumor antigens recognized by T cells: March 2004 updateCancer Immunology, Immunotherapy, 2004
- Cancer immunotherapy with mRNA‐transfected dendritic cellsImmunological Reviews, 2004
- T cell killing does not require the formation of a stable mature immunological synapseNature Immunology, 2004
- The shared tumor-associated antigen cytochrome P450 1B1 is recognized by specific cytotoxic T cellsBlood, 2003
- From cancer genomics to cancer immunotherapy: toward second-generation tumor antigensTrends in Immunology, 2001
- Minimal requirements for peptide mediated activation of CD8+ CTLMolecular Immunology, 1994
- Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass SpectrometryScience, 1992
- A Gene Encoding an Antigen Recognized by Cytolytic T Lymphocytes on a Human MelanomaScience, 1991